In this application we propose to develop microRNA and ultraconserved non coding RNA (UCR) biomarkers for the assessment of cancer risk and for the early detection of five different epithelial cancers, including the four most common malignant tumors (lung, breast, prostate, and colorectal cancer). A major reason, if not the major reason, of why these common epithelial tumors cause so much death and fail to respond to treatment is that by the time they are detected and diagnosed, the malignant cells have accumulated a large number of genetic and epigenetic alterations and have often acquired a "mutator" phenotype. During the past five years, we have established the microRNA expression profiles and, in some cases the UCR expression profiles, of the major human epithelial malignancies. On the basis of this extensive experience, now we intend to assess whether microRNA and UCR dysregulation can be detected in the serum of individuals at risk of developing cancer and at risk of cancer progression in order to develop non invasive biomarkers of cancer risk and for early detection. Such biomarkers could then be also exploited to follow the success of therapy.

National Institute of Health (NIH)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Sorbara, Lynn R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Downing, Nicholas S; Aminawung, Jenerius A; Shah, Nilay D et al. (2014) Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA 311:368-77
Gasparini, Pierluigi; Lovat, Francesca; Fassan, Matteo et al. (2014) Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A 111:4536-41
He, Wei A; Calore, Federica; Londhe, Priya et al. (2014) Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A 111:4525-9
Suh, Sung-Suk; Yoo, Ji Young; Cui, Ri et al. (2014) FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. PLoS Genet 10:e1004652
Volinia, Stefano; Nuovo, Gerard; Drusco, Alessandra et al. (2014) Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. J Natl Cancer Inst 106:
Buchsbaum, Donald J; Croce, Carlo M (2014) Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? JAMA 311:363-5
Di Leva, Gianpiero; Garofalo, Michela; Croce, Carlo M (2014) MicroRNAs in cancer. Annu Rev Pathol 9:287-314
Valeri, Nicola; Braconi, Chiara; Gasparini, Pierluigi et al. (2014) MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell 25:469-83
Gasparini, Pierluigi; Cascione, Luciano; Fassan, Matteo et al. (2014) microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget 5:1174-84
Lovat, Francesca; Ishii, Hideshi; Schiappacassi, Monica et al. (2014) LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. Oncotarget 5:970-7

Showing the most recent 10 out of 31 publications